110 related articles for article (PubMed ID: 2895747)
1. Effects of AHR-5333, a new potential antiallergy compound, in in vivo models of immediate hypersensitivity.
Yanni JM; Foxwell MH
Int Arch Allergy Appl Immunol; 1988; 85(4):428-33. PubMed ID: 2895747
[TBL] [Abstract][Full Text] [Related]
2. The in vivo and in vitro activity of AHR-13268D, a new antiallergic/antihistaminic agent.
Nolan JC; Foxwell MH; Whitman LL; Johnson DN; Yanni JM; Greene SV
Agents Actions; 1990 Nov; 31(3-4):210-8. PubMed ID: 1982201
[TBL] [Abstract][Full Text] [Related]
3. AHR-14310C: a potent, long-acting, nonsedating H1-antihistamine that prevents antigen-induced mucus formation in sensitive rats.
Nolan JC; Foxwell MH; Whitman LL; Yanni JM; Walsh DA; Kilpatrick BF; Johnson DN; Proakis AG
J Pharmacol Exp Ther; 1990 Jun; 253(3):1177-83. PubMed ID: 1972750
[TBL] [Abstract][Full Text] [Related]
4. Levocabastine: pharmacological profile of a highly effective inhibitor of allergic reactions.
Awouters F; Niemegeers CJ; Jansen T; Megens AA; Janssen PA
Agents Actions; 1992 Jan; 35(1-2):12-8. PubMed ID: 1354927
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and antiallergy activity of 4-(diarylhydroxymethyl)-1-[3-(aryloxy)propyl]piperidines and structurally related compounds.
Walsh DA; Franzyshen SK; Yanni JM
J Med Chem; 1989 Jan; 32(1):105-18. PubMed ID: 2562852
[TBL] [Abstract][Full Text] [Related]
6. BL-5255, a tetrazolylpyrimidinone with potent oral antiallergy activity in animals.
Siminoff P; Reed FC; Schurig JE; Juby PF
Monogr Allergy; 1979; 14():318-23. PubMed ID: 91959
[TBL] [Abstract][Full Text] [Related]
7. Rocastine (AHR-11325), a rapid acting, nonsedating antihistamine.
Nolan JC; Stephens DJ; Proakis AG; Leonard CA; Johnson DN; Kilpatrick BF; Foxwell MH; Yanni JM
Agents Actions; 1989 Aug; 28(1-2):53-61. PubMed ID: 2571244
[TBL] [Abstract][Full Text] [Related]
8. Antiallergic action of betotastine besilate (TAU-284) in animal models: A comparison with ketotifen.
Ueno M; Inagaki N; Nagai H; Koda A
Pharmacology; 1998 Oct; 57(4):206-14. PubMed ID: 9730778
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of immediate hypersensitivity reactions in laboratory animals by a phenanthroline salt (ICI 74,917).
Evans DP; Thomson DS
Br J Pharmacol; 1975 Mar; 53(3):409-18. PubMed ID: 48393
[TBL] [Abstract][Full Text] [Related]
10. Oxatomide, a new orally active drug which inhibits both the release and the effects of allergic mediators.
Awouters F; Niemegeers CJ; Van den Berk J; Van Neuten JM; Lenaerts FM; Borgers M; Schellekens KH; Broeckaert A; De Cree J; Janssen PA
Experientia; 1977 Dec; 33(12):1657-9. PubMed ID: 22455
[TBL] [Abstract][Full Text] [Related]
11. Bronchodilator and antiallergic effects of thiazinamium chloride in guinea pigs, rats, cats and dogs.
Lewis AJ; Dervinis A; Rosenthale ME
Eur J Pharmacol; 1982 May; 80(2-3):171-84. PubMed ID: 6125398
[TBL] [Abstract][Full Text] [Related]
12. Anti-anaphylactic activity of the novel selective histamine H1 receptor antagonist mizolastine in the rodent.
Levrier J; Duval D; Prouteau M; Voltz C; Berry CN; Lloyd KG; Scatton B
Arzneimittelforschung; 1995 May; 45(5):559-68. PubMed ID: 7541995
[TBL] [Abstract][Full Text] [Related]
13. Antiallergic effects of astemizole on immediate type hypersensitivity reactions.
Tasaka K; Akagi M; Izushi K; Mio M
Methods Find Exp Clin Pharmacol; 1990 Oct; 12(8):531-9. PubMed ID: 1709434
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological studies on the novel antiallergic drug HQL-79: I. Antiallergic and antiasthmatic effects in various experimental models.
Matsushita N; Hizue M; Aritake K; Hayashi K; Takada A; Mitsui K; Hayashi M; Hirotsu I; Kimura Y; Tani T; Nakajima H
Jpn J Pharmacol; 1998 Sep; 78(1):1-10. PubMed ID: 9804056
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of immediate hypersensitivity reaction by a new drug, RU-31156.
Koda A; Nagai H; Sato N; Nakatomi I; Nishiyori T; Mori H; Inagaki N
J Pharmacol; 1984; 15(3):353-73. PubMed ID: 6208430
[TBL] [Abstract][Full Text] [Related]
16. Effects of the new antiallergic drug 11-oxo-11H-pyrido[2,1-b] quinazoline-2-carboxylic acid on immediate allergic reactions.
Koda A; Nagai H; Mori H; Inagaki N; Nishiyori T; Matsuura N; Iwamoto T; Furukawa K; Yamada H; Goto S
Arzneimittelforschung; 1986 Nov; 36(11):1609-18. PubMed ID: 2434109
[TBL] [Abstract][Full Text] [Related]
17. Anti-allergic effects of ketanserin on animal models of allergic reactions.
Nagai H; Suda H; Kitagaki K; Goto S; Miura T; Koda A
Arch Int Pharmacodyn Ther; 1990; 307():172-82. PubMed ID: 1710442
[TBL] [Abstract][Full Text] [Related]
18. Airway closure after antigen challenge in cynomolgus monkeys: effect of the histamine H1 receptor antagonist, chlorpheniramine maleate.
Skeans S; Lamca JE; House A; Celly CS; Hey JA; Chapman RW
Int Arch Allergy Immunol; 2005 May; 137(1):37-44. PubMed ID: 15785080
[TBL] [Abstract][Full Text] [Related]
19. The antiallergy properties of U-17,660, a dibenzodiazepine.
Greig ME; Gibbons AJ; Young GA
Arch Int Pharmacodyn Ther; 1971 Apr; 190(2):299-308. PubMed ID: 4396925
[No Abstract] [Full Text] [Related]
20. Antiallergic profile of the novel H1-antihistaminic compound levocabastine.
Tasaka K; Kamei C; Akagi M; Mio M; Shirasaka T; Chokki M
Arzneimittelforschung; 1993 Dec; 43(12):1331-7. PubMed ID: 7511378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
